Thermo Fisher Scientific Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $9.31B | $6.79B | $2.52B | $230.0M |
| FY2022 | $9.15B | $6.91B | $2.24B | $307.0M |
| FY2023 | $8.41B | $6.93B | $1.48B | $278.0M |
| FY2024 | $8.67B | $7.27B | $1.40B | $301.0M |
| FY2025 | $7.82B | $6.29B | $1.53B | $310.0M |